Clinical Trials Directory

Trials / Unknown

UnknownNCT01088087

Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease

Effect of Colostrum Administration on Improving Gut Permeability and Serum Endotoxin Level in Chronic Alcohol Drinkers With Hepatic Dysfunction

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Gangnam Severance Hospital · Academic / Other
Sex
Male
Age
20 Years
Healthy volunteers
Accepted

Summary

Chronic alcohol ingestion is related with leaky gut syndrome. Colostrum is well-studied that it has a effect of decreasing the degree of leaky gut syndrome. So the investigators are planning to find out whether Colostrum has a effect of decreasing the degree of leaky gut syndrome.

Detailed description

We randomly sort the participant as placebo group and colostrum group. Each group consists of 17 people. and the duration of our study for one participant is 3 weeks. (Participant takes colostrum for 3 weeks.) When a person gets leaky gut syndrome, his or her endotoxin and lactulose/mannitol ratio (L/M ratio, in urine) can elevate. So We will compare the value of those two parameters and LFT. etc. after the administration of colostrum or placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcolostrumcolostrum, 2g, 2 times a day, for 3 weeks

Timeline

Start date
2010-03-01
Primary completion
2010-09-01
Completion
2010-12-01
First posted
2010-03-17
Last updated
2010-03-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01088087. Inclusion in this directory is not an endorsement.

Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease (NCT01088087) · Clinical Trials Directory